Psychedelic Commercialization: A Wide-Spanning Overview of the Emerging Psychedelic Industry.
Psychedelic Med (New Rochelle) September 13, 2023 DOI: 10.1089/psymed.2023.0013
Summary
As psychedelic medicines gain mainstream acceptance, a new billion-dollar industry is taking shape. Major pharmaceutical companies and startups are developing treatments using compounds like psilocybin and MDMA, while investors pour capital into research and infrastructure. This analysis reveals how the sector balances profit potential with ethical access and indigenous wisdom in bringing these medicines to market.
Abstract
Psychedelic Commercialization: A Wide-Spanning Overview of the Emerging Psychedelic Industry.